BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 95067)

  • 1. Common heat stable protective antigen in gonococci.
    Ito JI; Corbeil LB; Wunderlich AC; McCutchan JA; Braude AI
    Trans Assoc Am Physicians; 1979; 92():160-8. PubMed ID: 95067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
    Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
    mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective properties of gonococcal vaccines].
    Ovchinnikov NM; Timchenko GF
    Vestn Dermatol Venerol; 1976 Dec; (12):28-32. PubMed ID: 828819
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
    Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera.
    Tramont EC; Sadoff JC; Wilson C
    J Immunol; 1977 May; 118(5):1843-51. PubMed ID: 67149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for mimicking Neisserial saccharide epitopes as vaccines.
    Gulati S; Ngampasutadol J; Yamasaki R; McQuillen DP; Rice PA
    Int Rev Immunol; 2001; 20(2):229-50. PubMed ID: 11878767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection.
    Rice PA; Kasper DL
    J Clin Invest; 1977 Nov; 60(5):1149-58. PubMed ID: 409733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in attachment antigens of gonococci in reinfection.
    Tramont EC; Hodge WC; Gilbreath MJ; Ciak J
    J Lab Clin Med; 1979 May; 93(5):730-5. PubMed ID: 107257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine research for gonococcal infections: where are we?
    Jerse AE; Deal CD
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against infection with Neisseria gonorrhoeae by immunization with outer membrane protein complex and purified pili.
    Buchanan TM; Pearce WA; Schoolnik GK; Arko RJ
    J Infect Dis; 1977 Aug; 136 Suppl():S132-7. PubMed ID: 408428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies.
    Wetzler LM; Blake MS; Gotschlich EC
    Trans Assoc Am Physicians; 1989; 102():78-90. PubMed ID: 2561644
    [No Abstract]   [Full Text] [Related]  

  • 13. Human experimentation with Neisseria gonorrhoeae: progress and goals.
    Cohen MS; Cannon JG
    J Infect Dis; 1999 Mar; 179 Suppl 2():S375-9. PubMed ID: 10081510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More than one antigen contributes to the immunogenicity of Neisseria gonorrhoeae in the guinea pig chamber model.
    Parsons NJ; Penn CW; Veale DR; Smith H
    J Gen Microbiol; 1979 Jul; 113(1):97-104. PubMed ID: 91661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of immune responses in genital tracts of mice immunised with purified ribosomal fractions of Neisseria gonorrhoeae.
    Kita E; Kashiba S
    Br J Vener Dis; 1984 Aug; 60(4):219-25. PubMed ID: 6430462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the surface of Neisseria gonorrhoeae: simultaneous localization of protein I and H.8 antigens.
    Robinson EN; McGee ZA; Buchanan TM; Blake MS; Hitchcock PJ
    Infect Immun; 1987 May; 55(5):1190-7. PubMed ID: 3106215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress Toward a Gonococcal Vaccine: The Way Forward.
    Russell MW; Jerse AE; Gray-Owen SD
    Front Immunol; 2019; 10():2417. PubMed ID: 31681305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
    Gulati S; Zheng B; Reed GW; Su X; Cox AD; St Michael F; Stupak J; Lewis LA; Ram S; Rice PA
    PLoS Pathog; 2013; 9(8):e1003559. PubMed ID: 24009500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to gonococcal infection induced by vaccination with isolated outer membranes of Neisseria gonorrhoeae in guinea pigs.
    Buchanan TM; Arko RJ
    J Infect Dis; 1977 Jun; 135(6):879-87. PubMed ID: 405431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired and natural immunity to gonococcal infection in chimpanzees.
    Kraus SJ; Brown WJ; Arko RJ
    J Clin Invest; 1975 Jun; 55(6):1349-56. PubMed ID: 805797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.